United States · FDA National Drug Code directory
bupropion hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-3153_6a9ad5a3-18e0-4c86-b05e-df5f066c1900
- Product NDC
- 71335-3153
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- bupropion hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220801
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3153-1) · 71335-3153-1
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3153-2) · 71335-3153-2
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3153-3) · 71335-3153-3
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3153-4) · 71335-3153-4
- 14 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3153-5) · 71335-3153-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →